A recent article from The Guardian discussed a new blood test that screens for hard-to-detect cancers. The system, developed at Harvard Medical School’s Dana-Farber Cancer Institute, not only detects cancer, but also uses machine learning to indicate what type of cancer the patient has. The team behind the concept gave the system data related to methylation patterns in DNA from blood samples of over 2,800 patients. Roughly half of the sample group had cancer, while the other half did not.
Quick Hits: 50-in-1 Blood Test Detects Cancer Early
Researchers at Harvard Medical School have developed a new blood test that detects cancerous tumor DNA.
Apr 2, 2020
Recommended
Recommended
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
